Ex vivo efficacy study to evaluate neuroprotection in a retinal organotypic culture system: A gene therapeutic strategy to deliver growth factors to the retina to treat avascular age-related macular degeneration

被引：0
|
作者：
Kropp, M. [1 ,2 ]
Zedira, H. [1 ,2 ]
Conti, A. [1 ,2 ]
Bascuas-Castillo, T. [1 ,2 ]
Harmening, N. [1 ,2 ]
Thumann, G. [1 ,2 ]
机构：
[1] HUG, Geneva, Switzerland
[2] Univ Geneva, Geneva, Switzerland
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P315
引用
收藏
页码：A111 / A112
页数：2
相关论文
共 5 条
  • [1] Transposon-Based, Targeted Ex Vivo Gene Therapy to Treat Age-related Macular Degeneration
    Thumann, Gabriele
    HUMAN GENE THERAPY, 2013, 24 (12) : A31 - A31
  • [2] Transposon-Based, Targeted Ex Vivo Gene Therapy to Treat Age-related Macular Degeneration
    Thumann, Gabriele
    Kropp, Martina
    Harmening, Nina
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [3] Transposon-Based, Targeted Ex Vivo Gene Therapy to Treat Age-Related Macular Degeneration (TargetAMD)
    Thumann, Gabriele
    Perdikomati-Dahmen, Maria
    Izsvak, Zsuzsanna
    Ivics, Zoltan
    Garcia Layana, Alfredo
    Ronchetti, Mattia
    Petrovski, Goran
    Scherman, Daniel
    Aranda, Pablo
    Pouillot, Severine
    Binder, Susanne
    Johnen, Sandra
    Van den Berg, Joost
    HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2015, 26 (02) : 97 - 100
  • [4] Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration: the TargetAMD project
    Thumann, G.
    Kropp, M.
    Harmening, N.
    HUMAN GENE THERAPY, 2016, 27 (11) : A123 - A123
  • [5] A transposon-based gene therapy approach to treat avascular Age-Related Macular Degeneration (AMD) using mRNA transposase: results of the in vivo local and systemic toxicity study
    Kropp, M.
    Oezsahin, I.
    Harmening, N.
    Conti, A.
    Sealy, G.
    Breuillard, N.
    Mohit, M.
    Maccari, A.
    Bascuas, T.
    Thumann, G.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A75 - A75
1